12:00 AM
Feb 11, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Celldex completes follow-on

Celldex Therapeutics Inc. (NASDAQ:CLDX), Needham, Mass.
Business: Cancer, Infectious, Renal
Date completed: 2/5/13
Type: Follow-on

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >